Phil Secures $60 Million Growth Capital Facility from K2 HealthVentures to Accelerate AI Integration

portfolio company news
Written By Megan Prock McGrath

Phil, a leading software-driven pharmaceutical commercialization platform, today announced a $60 million growth debt financing from K2 HealthVentures (K2HV), a healthcare and life sciences-focused investment firm. The funding will accelerate the integration of artificial intelligence across Phil's platform and support continued customer expansion across a broad range of therapeutic areas.

Megan Prock McGrath
Next

Fuze Health Launches to Transform Patient Experiences and Enable Personalized Care in a Changing Healthcare Environment